Diverticulitis
Also known as: diverticular disease · diverticulosis
Free to read — no account needed. Sign in only to bookmark this disease and track your study progress.
ACG Clinical Guideline: Colonic Diverticulitis
American College of Gastroenterology (ACG) · 2026
This ACG guideline gives evidence-based recommendations for managing colonic diverticulitis in the outpatient gastroenterology setting, covering diagnosis, antibiotic use, follow-up colonoscopy and prevention of recurrence.
European Society of Coloproctology: guidelines for the management of diverticular disease of the colon
European Society of Coloproctology (ESCP) · 2020
ESCP's guideline summarises evidence on managing diverticular disease of the colon, written primarily as guidance for surgeons but intended for a broader clinical audience.
US vs EU key differences
- The two converge on selective antibiotics: the ACG guideline recommends against routine antibiotics for low-risk uncomplicated diverticulitis, and the ESCP guideline likewise reserves antibiotics for immunocompromised or septic patients. source
- Follow-up colonoscopy policy differs: ESCP advises colon examination at least 6 weeks after the episode for essentially all medically treated patients (exempting only those symptom-free after a single CT-verified uncomplicated episode, or scoped within 3 years), while the ACG guideline recommends it for complicated disease and only suggests it in uncomplicated cases with alarm symptoms or overdue colorectal cancer screening. source
- The ACG guideline adds explicit lifestyle-prevention advice, including that patients need not avoid nuts, seeds, corn or popcorn, alongside physical activity, weight management and limiting NSAIDs. source
- Version currency differs by roughly six years: the US guideline is a 2026 document, while the European Society of Coloproctology statements date to 2020. source
What changed recently
- US2021 → 20262026-07-01
ACG replaced its 2021 diverticular disease guideline with a document focused on colonic diverticulitis, formalising selective rather than routine antibiotics for low-risk acute uncomplicated disease and listing the high-risk features (immunocompromise, frailty, unsafe outpatient care) that still warrant them. It also recommends against probiotics, mesalamine and rifaximin for recurrence prevention, drops nut/seed/popcorn avoidance, and limits post-recovery colonoscopy to complicated disease or patients with alarm features or overdue screening.
source ↗curation confidence 90%
See the full update feed for changes across every system.